| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $23.05M | - | |
| Other | 52.8K | $8.66M | - | |
| Other | 46.8K | $7.68M | - | |
| Other | 39.6K | $6.51M | -36,937 | |
| Other | 36.8K | $6.05M | -11,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2017 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 2,955 | $75.00 | $221,625.00 | -18.3% | |
| Dec 4, 2017 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 6,279 | $75.04 | $471,159.83 | -32.3% | |
| Dec 1, 2017 | Lyons Gary A54 | Director | Sell | 10,000 | $72.92 | $729,182.00 | -3.5% | |
| Nov 15, 2017 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 9,900 | $73.05 | $723,191.04 | -42.9% | |
| Nov 8, 2017 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 30,000 | $74.58 | $2,237,343.00 | -27.9% | |
| Nov 2, 2017 | Gano Kyle54 | Chief Business Development Off | Sale+OE | 24,818 | $71.05 | $1,763,318.90 | -14.5% | |
| Nov 2, 2017 | Obrien Christopher Flint | Chief Medical Officer | Sale+OE | 52,817 | $69.71 | $3,681,640.68 | -35.0% | |
| Oct 2, 2017 | Obrien Christopher Flint | Chief Medical Officer | Sale+OE | 6,925 | $61.04 | $422,702.00 | -12.4% | |
| Sep 6, 2017 | Gano Kyle54 | Chief Business Development Off | Sale+OE | 20,393 | $60.00 | $1,223,580.00 | -21.8% | |
| Sep 6, 2017 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 100 | $60.00 | $6,000.00 | -0.8% |